New Drugs, Fair Prices addresses the important question of how we might
get the innovative new medicines we need at prices we can afford. Today,
this debate is impassioned but sterile. One side calls for price
controls, discounting their impact on investment in innovation. The
other points to miraculous new therapies, disregarding their
affordability and social inequity. This polarized argument creates more
heat than light, threatening the social contract between the industry
and society on which pharmaceutical innovation depends.
This ground-breaking book takes a wholly new perspective on the issue
and raises the debate to a more informed and productive level. Drawing
on interviews with more than 70 experts across the pharmaceutical
innovation world and combining a diverse literature from scientific,
political, economic and business domains, it describes how a sustainable
and affordable supply of new medicines is possible only by balancing
pharmaceutical innovation's complex, adaptive ecosystem. By considering
how each of the ecosystem's seven habitats work and interact with the
others, it makes a comprehensive set of recommendations for achieving
that ecosystem balance.
The core message of New Drugs, Fair Prices is important to anyone who
ever has needed or will ever need a medicine: we can have a sustainable
supply of new medicines that are both innovative and affordable if we
manage the pharmaceutical innovation ecosystem intelligently.
